Up to two years of pridopidine treatment continues to slow Huntington’s disease progression among patients not taking certain standard treatments called antidopaminergic medications (ADMs). That’s according to a new analysis […] The post Pridopidine shows long-term benefit for some Huntington’s patients appeared first on Huntington's Disease News.
